Medical agent for improving and treating mental symptoms induced by cerebral disturbances
US4609656A · kind A · utility
0Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 1985 |
| Grant date | Sep 2, 1986 |
| Priority date | — |
| Expiry date | Jul 24, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A medical agent for improving and treating mental symptoms induced by cerebral disturbances comprising a composition containing 2-(7-indenyloxymethyl)morpholine (generic name: indeloxazine) or an acid addition salt thereof as the effective component. Preferred examples of the acid addition salt are the hydrochloride, sulfate, maleate, etc.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.